Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 40 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 23 | 974−3.8%/yr | −3.8%/yr | 3.71.2× | 9% | 890 in 2030−1.4%/yr |
| Lumbar fusion | 31 | 952+2%/yr | +2%/yr | 3.61.3× | 3% | 1,140 in 2030+3.1%/yr |
| Kyphoplasty & vertebroplasty | 6 | 473−8.9%/yr | −8.9%/yr | 1.81.3× | 16% | 510 in 2030+1.3%/yr |
| Cervical fusion & disc arthroplasty | 8 | 406−2.1%/yr | −2.1%/yr | 1.51.1× | 6% | 480 in 2030+2.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 89 | 14,750−3.9%/yr | −3.9%/yr | 54.90.7× | 30% | 17,600 in 2030+3%/yr |
| Skin substitutes & wound grafts | 10 | 2,307+4.5%/yr | +4.5%/yr | 6.60.9× | 54% | 3,570 in 2030+7.5%/yr |
| Bone graft & orthobiologics | 6 | 320−12%/yr | −12%/yr | 1.21.9× | 3% | 320 in 2030+0.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 37 | 2,646+7.2%/yr | +7.2%/yr | 9.81.1× | 71% | 4,000 in 2030+7.1%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 7 | 421+7.4%/yr | +7.4%/yr | 1.51.4× | 66% | 620 in 2030+6.8%/yr |
| Spinal cord & DRG stimulation | 5 | 200−5.3%/yr | −5.3%/yr | 0.71.0× | 65% | 270 in 2030+5.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 9 | 1,170−1.7%/yr | −1.7%/yr | 4.41.1× | 62% | 2,150 in 2030+11%/yr |
| Superficial venous ablation | 10 | 562−6.2%/yr | −6.2%/yr | 2.10.6× | 70% | 590 in 2030+0.9%/yr |
| Dialysis access | 7 | 526−11%/yr | −11%/yr | 2.10.4× | 3% | 610 in 2030+2.4%/yr |
| Carotid revascularization | 5 | 321−9.6%/yr | −9.6%/yr | 1.21.1× | 0% | 410 in 2030+4.2%/yr |
| Thrombectomy, IVC filters & venous stents | 1 | 272−1.9%/yr | −1.9%/yr | 1.10.7× | 0% | 220 in 2030−3.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 17 | 1,596−3.4%/yr | −3.4%/yr | 6.41.0× | 14% | 1,920 in 2030+3.1%/yr |
| Cholecystectomy & appendectomy | 33 | 1,242−5.8%/yr | −5.8%/yr | 4.91.1× | 7% | 1,320 in 2030+1%/yr |
| Colorectal resection | 2 | 506−3.8%/yr | −3.8%/yr | 2.01.1× | 0% | 480 in 2030−0.8%/yr |
| Antireflux & hiatal hernia surgery | 5 | 255+2.2%/yr | +2.2%/yr | 1.01.3× | 0% | 370 in 2030+6.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 35 | 1,512−0.1%/yr | −0.1%/yr | 5.81.1× | 12% | 1,880 in 2030+3.7%/yr |
| BPH procedures | 20 | 1,469−17%/yr | −17%/yr | 5.61.2× | 29% | 1,250 in 2030−2.7%/yr |
| Incontinence, prolapse & sacral neuromodulation | 12 | 849−2%/yr | −2%/yr | 3.21.5× | 24% | 1,020 in 2030+3.1%/yr |
| Hysterectomy, hysteroscopy & ablation | 4 | 529−3.8%/yr | −3.8%/yr | 2.20.7× | 9% | 650 in 2030+3.6%/yr |
| Prostatectomy & nephrectomy | 9 | 452+0.8%/yr | +0.8%/yr | 1.81.3× | 0% | 520 in 2030+2.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 19 | 1,127−1.5%/yr | −1.5%/yr | 4.41.2× | 82% | 1,010 in 2030−1.8%/yr |
| Sleep apnea & airway implants | 2 | 105+149%/yr | +149%/yr | 0.41.9× | 19% | 90 in 2030−2.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 32 | 1,959−0.6%/yr | −0.6%/yr | 7.91.1× | 31% | 2,180 in 2030+1.8%/yr |
| Tumor & fibroid embolization | 2 | 116+16%/yr | +16%/yr | 0.40.9× | 23% | 210 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 54 | 8,132+36%/yr | +36%/yr | 30.91.1× | 76% | 14,300 in 2030+9.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 20 | 1,389−4%/yr | −4%/yr | 5.51.0× | 4% | 1,420 in 2030+0.4%/yr |
| LAA occlusion & loop recorders | 22 | 1,071+16%/yr | +16%/yr | 3.81.2× | 3% | 1,730 in 2030+8.3%/yr |
| EP ablation | 15 | 802+7.1%/yr | +7.1%/yr | 2.80.9× | 0% | 1,560 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 31 | 1,417−6.6%/yr | −6.6%/yr | 4.80.8× | 2% | 1,490 in 2030+0.8%/yr |
| Structural heart (TAVR, TEER) | 26 | 451+5.5%/yr | +5.5%/yr | 1.50.9× | 0% | 490 in 2030+1.4%/yr |
| Mechanical circulatory support | 0 | 154−1.7%/yr | −1.7%/yr | 0.60.9× | 0% | 460 in 2030+20%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 48 | 17,332+0.1%/yr | +0.1%/yr | 65.81.0× | 75% | 20,900 in 2030+3.2%/yr |
| Vitreoretinal surgery | 9 | 735−1.3%/yr | −1.3%/yr | 2.81.2× | 72% | 740 in 20300%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 135 | 27,462−1.7%/yr | −1.7%/yr | 108.20.9× | 51% | 28,600 in 2030+0.7%/yr |
| ERCP & endoscopic ultrasound | 11 | 985−1.3%/yr | −1.3%/yr | 3.81.0× | 3% | 1,130 in 2030+2.4%/yr |
| Bronchoscopy & lung nodule | 19 | 940+6.3%/yr | +6.3%/yr | 3.61.0× | 0% | 1,420 in 2030+7.1%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.